Search Videos and More
Course
Complex Patient Case Review for Oncologic and Benign Urology
Live Webinar | 5:00 PM - 6:00 PM EDT | Wednesday, May 21, 2025
News
New Fox Chase Cancer Center Study Shows Partially Absorbable Mesh Significantly Lowers Parastomal Hernia Risk Following Bladder Removal
Parastomal hernia is a common complication among patients who undergo bladder removal and ileal conduit urinary diversion. Now, a new study “Very Low Rate of Parastomal Hernia Using Partially Absorbable Macroporous Mesh for Prophylactic Reinforcement in Ileal Conduit Urinary Diversion: A Collaborative Approach Between Urology and Plastic/Reconstructive Surgery,” presented by Fox Chase Cancer Center clinicians at the American Urological Association’s (AUA) 2025 Annual Meeting supports the use of partially absorbable synthetic, non-biologic parastomal mesh to significantly reduce this risk in real-world practice.
News
AUA 2025 Speaker and Poster Sessions
Visit the Fox Chase-Temple Urologic Institute Booth #2253 in the Science & Technology Hall (Expo Halls A,B,C).
News
Local Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds
Results from a study presented by Fox Chase Cancer Center researchers at the Society of Surgical Oncology 2025 Annual Meeting suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer.
News
Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer
Removing and testing at least 18 lymph nodes during surgery was associated with more accurate staging and better survival rates for colon cancer patients, according to research presented today at the Society of Surgical Oncology 2025 Annual Meeting. The findings from researchers at Fox Chase Cancer Center challenge the current standard of care for staging colon cancer, which calls for removal and examination of 12 lymph nodes.
News
INSITE Trial Looking to Identify Which Patients Can Forgo Cystectomy
Alexander Kutikov, MD, FACS, and Matthew R. Zibelman, MD, are conducting a new trial called INSITE to attempt to answer that question.
News
ASCO Genitourinary Cancer Symposium 2025: Fox Chase Advances Cancer Prevention, Research, and Potential Cures
This year, Fox Chase faculty and Fellows presented research that revealed tangible benefits for genitourinary cancer patient outcomes and quality of life.
Course
Monthly Multi-Institutional Hematopathology Interesting Case Conference
Please join us for our next Monthly Multi-Institutonal Hematopathology Interesting Case Conference (MHICC). A collaborative meeting that brings together pathologists, clinicians and researchers from renowned institutions to discuss challenging and educational hematopathology cases
News
A tragic death becomes a life force.
“A defining moment in my life was when my father was diagnosed with glioblastoma. At the time, we lived in New York’s Hudson Valley, and no area medical center offered treatment for a serious and complicated diagnosis like his. The only available therapy was in Manhattan, so at age 16, with just a learner’s permit, I drove my dad into the city to fight for his life while I maneuvered the George Washington Bridge as a novice driver,” says James P. Nitzkorski, MD, FACS, FSSO, a former Surgical Oncology Fellow at Fox Chase Cancer Center, and now, a surgical oncologist at Nuvance Health and Program Director for the General Surgery Residency at Vassar Brothers Medical Center, both in Poughkeepsie, NY. His father’s experience p
Symposium
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
The management of advanced kidney, bladder, and prostate cancer is rapidly evolving, and new robotic and minimally invasive surgical techniques are now available. Presented by the nationally recognized Fox Chase Cancer Center genitourinary oncology team—comprising experts in urology, radiation therapy, and medical oncology—this program will cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.
News
Jay Simhan, MD, FACS Named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University
Jay Simhan, MD, FACS, has been named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University.
News
Preventing Lymphedema Right from the Start:
Using Advanced Microsurgery During Cancer Surgery